Insigneo Advisory Services’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$308K Sell
843
-167
-17% -$57.1K 0.01% 630
2026
Q2
$288K Buy
+1,010
New +$298K 0.01% 652

Other funds holding ONC

Insigneo Advisory Services's ONC Position: Q3 2026 in Review

Insigneo Advisory Services reduced its BeOne Medicines (ONC) stake by 17% in Q3 2026, selling an estimated $57.1K and leaving 843 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #630.

Insigneo Advisory Services first reported a position in ONC in Q2 2026 and has held it in 2 quarters since. 318 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Insigneo Advisory Services held 843 shares of BeOne Medicines worth $308K as of Q3 2026.
  • Insigneo Advisory Services sold 167 BeOne Medicines shares in Q3 2026, an estimated $57.1K.
  • BeOne Medicines made up 0.01% of Insigneo Advisory Services's portfolio in Q3 2026, its #630 holding.
  • Insigneo Advisory Services first reported a position in BeOne Medicines in Q2 2026 and has held it in 2 quarters since.
  • 318 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on Insigneo Advisory Services's 13F filing for Q3 2026, filed 13 Nov 2026.